Modulation of primary human immunodeficiency virus type 1 envelope glycoprotein-mediated entry by human antibodies

Journal of General Virology

Volumn 78, Issue 5, 1997, Pages 999-1006

  Schutten, Martin ^a   Andeweg, Arno C ^a,b   Rimmelzwaan, Guus F ^a   Osterhaus, Albert D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY AFFINITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE SENSITIVITY; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS NEUTRALIZATION;

EID: 0030995840     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-5-999     Document Type: Article

References (45)

1. Allan, J. S. (1991). Receptor-mediated activation of immunodeficiency viruses in viral fusion. Science 252, 1322-1323.
2. Andeweg, A. C., Groenink, M., Leeflang, P., de Goede, R. E. Y., Osterhaus, A. D. M. E., Tersmette, M. & Bosch, M. L. (1992). Genetic and functional analysis of a set of HIV-1 envelope genes obtained from biological clones with varying syncytium-inducing capacities. AIDS Research and Human Retroviruses 8, 1803-1813.
3. Andeweg, A. C., Leeflang, P., Osterhaus, A. D. M. E. & Bosch, M. L. (1993). Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation. Journal of Virology 67, 3232-3239.
4. Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P. W., Sawyer, L. S., Hendry, R. M., Dunlop, N., Nara, P. L., Lamacchia, M., Garratty, E., Stiehm, E. R., Bryson, Y. J., Moore, J. P., Ho, D. D. & Barbas, C. F., III (1994). Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027.
5. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C. & Sodroski, J. (1996). The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
6. Clapham, P. R., Weber, J. N., Whitby, D., Mcintosh, K., Dalgleish, A. G., Maddon, P. J., Deen, K. C., Sweet, R. W. & Weiss, R. A. (1989). Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature 337, 368-370.
7. Clapham, P. R., McKnight, A. & Weiss, R. A. (1992). Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. Journal of Virology 66, 3531-3537.
8. de Jong, J. J., Goudsmit, J., Keulen, W., Klaver, B., Krone, W., Tersmette, M. & de Ronde, A. (1992). Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. Journal of Virology 66, 757-765.
9. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzi, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R. & Landau, N. R. (1996). Identification of a major co-receptor for primary isolates of HIV-1, Nature 381, 661-666.
10. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G. & Doms, R. W. (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
11. Eaton, A. M., Ugen, K. E., Weiner, D. B., Wildes, T. & Levy, J. A. (1994). An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement. AIDS Research and Human Retroviruses 10, 13-18.
12. Feng, Y., Broder, C. C., Kennedy, P. E. & Berger, E. A. (1996). HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
13. Gluzman, Y. (1981). SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23, 175-182.
14. Gorny, M. K., Xu, J. Y., Karwowska, S., Buchbinder, A. & Zolla-Pazner, S. (1993). Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HTV-1 gp120. Journal of Immunology 150, 635-643.
15. Groenink, M., Andeweg, A. C., Fouehier, R. A. M., Broersen, S., van der Jagt, R. C., Schuitemaker, H., de Goede, R. E. Y., Bosch, M. L., Huisman, H. G. & Tersmette, M. (1992). Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: evidence for in vivo recombination and determinants of cytotropism outside the V3 domain. Journal of Virology 66, 6175-6180.
16. Helseth, E., Kowalski, M., Gabuzda, D., Olshevsky, U., Haseltine, W. & Sodroski, J. (1990). Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. Journal of Virology 64, 2416-2420.
17. Innocenti-Francillard, P., Brengel, K., Guillon, C., Mallet, F., Morand, P., Gruters, R. & Seigneurin, J. M. (1994). Blood monocytes infected in vivo by HIV-1 variants with a syncytium-inducing phenotype. AIDS Research and Human Retroviruses 10, 683-690.
18. Kostrikis, L. G., Cao, Y., Ngai, H., Moore, J. P. & Ho, D. D. (1996). Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement. Journal of Virology 70, 445-458.
19. Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A. & Axel, R. (1986). The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47, 333-348.
20. Malvoisin, E. & Wild, F. (1994). Analysis of the human immunodeficiency virus type 1 envelope protein interaction with the CD4 host cell receptor. Journal of General Virology 75, 839-847.
21. Moore, J. P. (1990). Simple methods for monitoring HIV-1 and HIV-2 gp120 binding to soluble CD4 by enzyme-linked immunosorbent assay: HIV-2 has a 25-fold lower affinity than HIV-1 for soluble CD4. AIDS 4, 297-305.
22. Moore, J. P., McKeating, J. A., Weiss, R. A. & Sattentau, Q. J. (1990). Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1139-1142.
23. Moore, J. P., McKeating, J. A., Weiss, R. A., Clapham, P. R. & Sattentau, Q. J. (1991). Receptor mediated activation of immunodeficiency viruses in viral fusion. Science 252, 1322-1323.
24. Moore, J. P., McKeating, J. A., Huang, Y. X., Ashkenazi, A. & Ho, D. D. (1992). Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates. Journal of Virology 66, 235-243.
25. Moore, J. P., Cao, Y., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., III, Burton, D. R. & Ho, D. D. (1995). Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. Journal of Virology 69, 101-109.
26. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Ruker, F. & Katinger, H. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology 67, 6642-6647.
27. Orloff, S. L., Kennedy, M. S., Belperron, A. A., Maddon, P. J. & McDougal, J. S. (1993). Two mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4. Journal of Virology 67, 1461-1471.
28. Poignard, P., Fouts, T., Naniche, D., Moore, J. P. & Sattentau, Q. J. (1996). Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation. Journal of Experimental Medicine 183, 473-484.
29. Roben, P., Moore, J. P., Thali, M., Sodroski, J., Barbas, C. F., III & Burton, D. R. (1994). Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. Journal of Virology 68, 4821-4828.
30. Robinson, W. E., Jr, Montefiori, D. C. & Mitchell, W. M. (1990). Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175, 600-604.
31. Sattentau, Q. J. & Moore, J. P. (1991). Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. Journal of Experimental Medicine 174, 407-415.
32. Sattentau, Q. J., Moore, J. P., Andeweg, A. C., Schutten, M., Osterhaus, A. D. M. E. & Schuitemaker, H. (1994). HIV-1 neutralization: antibody-gp120 interactions. In Neuvième Colloque Des Cent Gardes, pp. 135-139. Marnes-La Coquette/Paris, France.
33. Schuitemaker, H., Koot, M., Kootstra, N. A., Dercksen, M. W., de Goede, R. E. Y., van Steenwijk, R. P., Lange, J. M., Schattenkerk, J. K., Miedema, F. & Tersmette, F. (1992). Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. Journal of Virology 66, 1354-1360.
34. Schutten, M., McKnight, A., Huisman, R. C., Thali, M., McKeating, J. A., Sodroski, J., Goudsmit, J. & Osterhaus, A. D. M. E. (1993). Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies. AIDS 7, 919-923.
35. Schutten, M., Andeweg, A. C., Bosch, M. L. & Osterhaus, A. D. M. E. (1995 a). Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium inducing HIV-1. Scandinavian Journal of Immunology 41, 18-22.
36. Schutten, M., Langedijk, J. P. M., Andeweg, A. C., Huisman, R. C., Meloen, R. H. & Osterhaus, A. D. M. E. (1995 b). Characterization of a V3 domain-specific neutralizing human monoclonal antibody that preferentially recognizes non-syncytium-inducing human immunodeficiency virus type 1 strains. Journal of General Virology 76, 1665-1673.
37. Schutten, M., Tenner-Racz, K., Racz, P., Van Bekkum, D. W. & Osterhaus, A. D. M. E. (1996). Human antibodies that neutralize primary human immunodeficiency virus type 1 in vitro do not provide protection in an in vivo model. Journal of General Virology 77, 1667-1675.
38. Seed, B. & Sheen, J. (1988). A simple phase extraction assay for chloramphenicol acetyltransferase activity. Gene 67, 271-277.
39. Smith, S. D., Shatsky, M., Cohen, P. S., Warnke, R., Link, M. P. & Glader, B. E. (1984). Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Research 44, 5657-5660.
40. Stein, B. S., Gowda, S. D., Lifson, J. D., Penhallow, R. C., Bensch, K. G. & Engleman, E. G. (1987). pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49, 659-668.
41. Sullivan, N., Sun, Y., Li, J., Hofmann, W. & Sodroski, J. (1995). Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. Journal of Virology 69, 4413-4422.
42. Teeuwsen, V. J. P., Siebelink, C. H. J., Crush-Stanton, S., Swerdlow, B., Schalken, J. J., Goudsmit, J., van de Akker, R., Stukart, M. J., Uytdehaag, F. G. C. M. & Osterhaus, A. D. M. E. (1990). Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I. AIDS Research and Human Retroviruses 6, 381-392.
43. Werner, A., Winskowsky, G. & Kurth, R. (1990). Soluble CD4 enhances simian immunodeficiency virus SIVagm infection. Journal of Virology 64, 6252-6256.
44. Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., Gerard, G. & Sodroski, J. (1996). CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384, 179-183.
45. Zolla-Pazner, S., O'Leary, J., Burda, S., Gorny, M. K., Kim, M., Mascola, J. & McCutchan, F. (1995). Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. Journal of Virology 69, 3807-3815.